FDA Approved: XIPERE — Original Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved XIPERE (triamcinolone acetonide) through an original application for the treatment of macular edema following retinal vein occlusion, delivered as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema Following Retinal Vein Occlusion

Drugs mentioned

• XIPERE (TRIAMCINOLONE ACETONIDE)

Snippet

ORIG AP for XIPERE (TRIAMCINOLONE ACETONIDE)